CATALYST PHARMACEUTICAL |
USA |
Gesundheit |
US14888U1016 / A0LCUL |
CN2 (Frankfurt) / CPRX (NASDAQ) |
FRA:CN2, ETR:CN2, CN2:GR, NASDAQ:CPRX |
- |
https://catalystpharma.co.. |
2470 Mio. EUR |
462.9 Mio. EUR |
233.05 Mio. EUR |
1.169 EUR |
2.68 Mio. EUR |
502.73 Mio. EUR |
43.6% / 143.8% |
15.15 / 12.82 |
5.6 / 3.65 / - |
36.91% / 29.11% |
- |
- / - |
CATALYST PHARMACEUTICAL, CATALYST PHARMACEUTICALS, CATALYST PHARMA |
25.06.25 |
|
||||
|